exenatide and ramelteon

exenatide has been researched along with ramelteon* in 2 studies

Other Studies

2 other study(ies) available for exenatide and ramelteon

ArticleYear
A look back at the most influential drug approvals of 2005.
    The Nurse practitioner, 2006, Volume: 31, Issue:2

    Topics: Amyloid; Analgesics; Anticonvulsants; Antiparkinson Agents; Diabetes Mellitus, Type 2; Diphtheria-Tetanus-Pertussis Vaccine; Drug Approval; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Exenatide; gamma-Aminobutyric Acid; Heart Failure; Humans; Hydralazine; Hypoglycemic Agents; Indenes; Indoles; Islet Amyloid Polypeptide; Isosorbide Dinitrate; Patient Education as Topic; Patient Selection; Peptides; Pregabalin; Sleep Wake Disorders; United States; United States Food and Drug Administration; Venoms

2006
Practical considerations of new drugs: new choices for old problems.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2006, Volume: 21, Issue:4

    As drug therapy experts, pharmacists are often called upon for facts and opinions about recently introduced drugs. New drugs are introduced at a rate that exceeds the reading time of many busy practitioners. This article is intended to provide an objective information and broad-based discussion about new drug options that have particular relevance for the elderly. Drugs that will be reviewed include: acamprosate, darifenacin, eszopiclone, exenatide, ibandronate, nitazoxanide, pramlintide, pregabalin, ramelteon, tigecycline, tinidazole, trospium, and solifenacin.

    Topics: Advertising; Aged; Amyloid; Analgesics; Anti-Bacterial Agents; Azabicyclo Compounds; Clinical Trials as Topic; Drug Labeling; Exenatide; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Hypoglycemic Agents; Indenes; Islet Amyloid Polypeptide; Minocycline; Peptides; Piperazines; Pregabalin; Tigecycline; Venoms

2006